A West Coast biotechnology firm says it will pour $2.5 million into
research at Scripps Florida over the next 26 months to develop new anti-cancer
and other drugs.
In return, Seattle-based NeoRx will have exclusive global rights to commercialize the compounds developed through the partnership. |
[CML] A group of CMLHope.Com Subscribe: [EMAIL PROTECTED] Web Site: http://groups.cmlhope.com